CSBR: championsoncology.com Kompaniya qiymatining sof foydaga nisbati

Champions Oncology, Inc. - CSBR emitenti grafik logotipi

Champions Oncology (CSBR) kompaniyasining -60.10 indikatori bilan ko'rsatilgan ushbu kunlik narxlar grafigi, onkologik dori vositalarini ishlab chiqishdan tushadigan daromadlari sikllilikka minimal darajada bog'liq bo'lgan biznesning makro-barqarorligini ta'kidlaydi. Rahbariyat farmatsevtika sektori bilan ittifoqlar sonini oshirishni va ilg'or tahlil tizimlarini joriy qilishni maqsad qilgan. Moliyaviy barqarorlik sanoat gigantlari orasida o'simta IT modellariga bo'lgan talabga tayanadi, kompaniya esa mijozlar budjetlari qayta ko'rib chiqilayotgan davrlarda xarajatlarni qat'iy nazorat qiladi.

Narx-foyda koeffitsiyenti: Champions Oncology Corp (CSBR) 04.07.2022 - 17.11.2026 uchun

Champions Oncology Inc (CSBR) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning jamlanma tahlili:CSBR Champions Oncology, Inc.
Champions Oncology, Inc. yetakchi tovari

Champions Oncology (CSBR) kompaniyasining kredit sifatini baholash uchun tahlilchi biznesning bozor qiymatini uning sof foyda keltirish borasidagi haqiqiy qobiliyati bilan solishtiradi, bu tendentsiya narxning foydaga nisbati (P/E) koeffitsienti orqali aks etadi. AI platformalari bilan bo'lgan shiddatli raqobat sharoitida, ushbu ko'rsatkich shaxsiylashtirilgan terapiyaning kengayish premiumini o'lchaydi, bunda koeffitsiyentning o'sishi bozorning kompaniyaning kengayishiga bo'lgan ishonchini anglatadi, pasayishi esa nish bozorini egallash sur'atlarining sekinlashishi risklarini aks ettiradi.

Muhim raqobatchilar

ONC: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti HALO (Halozyme Inc.)|RVMD (RevMed) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AAPG (ascentage.com)|CGON - Narx-foyda koeffitsiyenti|URGN: Narx-foyda koeffitsiyenti|BCAX - P/E multiplikatori|Personalis Corp (PSNL) - Narxning foydaga nisbati|Erasca Corp - Kompaniya qiymatining sof foydaga nisbati|DCTH (Delcath Systems Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Y-mAbs Therapeutics, Inc. YMAB|P/E multiplikatori AURA|Narx-foyda koeffitsiyenti Candel Therapeutics, Inc. CADL|P/E multiplikatori ARAY (Accuray, Inc.)|SELLAS Life Sciences - Narxning foydaga nisbati|ACTU: Narx-foyda koeffitsiyenti|Citius Oncology, Inc. - Bozor narxining sof foydaga nisbati|HURA (TuHURA Biosciences) - Narx-foyda koeffitsiyenti|TARA: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti FATE|WHWK: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TCRX (TScan Therapeutics Inc)|XBIT - Kapitalizatsiyaning foydaga nisbati|CEL-SCI Corporation - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OSTX|radiopharmtheranostics.com - P/E multiplikatori|ARTV: Narxning foydaga nisbati|ANL (adlainortye.com) - Narx-foyda koeffitsiyenti|VERU - Biznesning o‘zini qoplash muddati|TPST (Tempest Therapeutics, Inc.) - P/E multiplikatori|P/E multiplikatori xiliotx.com|Narxning foydaga nisbati Enochian BioSciences (RENB)|Narxning foydaga nisbati MURA (Mural Oncology PLC)|Narxning foydaga nisbati Kairos Pharma Ltd KAPA|P/E multiplikatori OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - P/E multiplikatori|Biznesning o‘zini qoplash muddati Curis CRIS|APLM: P/E multiplikatori|Narx-foyda koeffitsiyenti Tharimmune, Inc.|ADVB (Advanced Biomed) - P/E multiplikatori|Genprex - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Kapitalizatsiyaning foydaga nisbati|PPBT: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Narxning foydaga nisbati|Checkpoint Therapeutics, Inc (CKPT) - P/E multiplikatori|Narxning foydaga nisbati Elevation Oncology, Inc.|ICAD: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati ikenaoncology.com (IKNA)|Narxning foydaga nisbati NTBL (Notable Labs, Ltd.)|P/E multiplikatori VIRX (viracta.com)|MOR - Narx-foyda koeffitsiyenti|NAYA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati AAPGV